Clifford A Hudis, MD-MSK Breast Oncologist

Dr. Mahmoud El-Tamer, MD, is a distinguished Breast Surgeon practicing at Memorial Sloan Kettering Cancer Center in New York, NY. With over 30 years of experience, Dr. El-Tamer specializes in oncoplastic procedures, combining cancer removal with breast reconstruction to ensure optimal outcomes for his patients. Devoted to enhancing both physical health and appearance, Dr. El-Tamer's expertise benefits over 350 individuals facing breast cancer annually. He guides patients through their options, addressing concerns and tailoring treatments to meet their unique needs, empowering them to make informed decisions about their care. Dr. El-Tamer is not only a skilled practitioner but also a dedicated researcher, actively involved in clinical trials to advance breast cancer treatment. His contributions extend to educating future surgeons, authoring numerous publications, and leading workshops to improve surgical techniques and cosmetic results in breast cancer care. Generated from the website content

I am a board-certified medical oncologist with a practice that is dedicated to the treatment of patients with breast cancer. I provide my patients with individualized treatment plans based upon the most up-to-date research and therapies. I strive to provide compassionate care, to communicate effectively with my patients and to assist them in making informed decisions about their care. My research program is focused on understanding and working to reduce disparities in breast cancer outcomes.

Mark E. Robson, MD is a distinguished Breast Medical Oncologist & Clinical Geneticist based in New York, NY. Specializing in identifying and managing individuals with an inherited risk for cancer, Dr. Robson focuses on incorporating genetic information into personalized treatment plans. His expertise extends to developing preventive strategies for high-risk individuals and optimizing outcomes for those with hereditary cancers. Dr. Robson's practice places a significant emphasis on the care of young women with breast cancer, particularly those with hereditary forms. Actively involved in advancing treatment options such as PARP inhibitors for this specific patient population, he strives to enhance therapeutic approaches. Additionally, he oversees specialized screening programs for women carrying mutations in BRCA1 or BRCA2. As Chief of the Breast Medicine Service, Dr. Robson brings a wealth of experience in breast cancer management. Noteworthy for his work in genetic risk assessment and personalized treatments, he is recognized for his commitment to improving outcomes for patients with breast cancers and hereditary conditions. Dr. Robson's dedication to bridging genetics and oncology underscores his pivotal role in patient care and research at Mark E. Robson, MD. Generated from the website content